Viking Therapeutics
VKTX
VKTX
407 hedge funds and large institutions have $3.3B invested in Viking Therapeutics in 2024 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 146 increasing their positions, 126 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
407
Holders Change
-13
Holders Change %
-3.1%
% of All Funds
5.42%
Holding in Top 10
2
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
83
Increased
146
Reduced
126
Closed
88
Calls
$296M
Puts
$164M
Net Calls
+$132M
Net Calls Change
-$90.2M
Top Buyers
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
$54.6M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
$59.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
$34.6M |
| 4 |
Morgan Stanley
New York
|
$104M |
| 5 |
BlackRock
New York
|
$236M |
